NICE approves using SIR-Spheres as alternative HCC treatment

The National Institute for Health and Care Excellence released a Medtech Innovation Briefing stating SIR-Spheres ytrrium-90 resin microspheres may be used as an alternative to standard therapy for the treatment of patients with inoperable primary hepatocellular carcinoma. Y-90 resin microspheres are tiny radioactive ‘beads’ used in selective internal radiation therapy for the treatment of stage IV colon cancer that has spread to the liver and cannot be surgically removed.